Ajanta Pharma Limited has informed the Exchange about General Updates

Board & Shareholder Meetings View source PDF

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.9%1-day move

₹2900.00

prior close

₹2958.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.6+0.6+1.6+5.9+4.6+5.2+6.4+7.8+9.6+4.3+2.4+16.4—

Up moveDown movePending

AI summary

Ajanta Pharma's Board meeting on 5th May 2026 approved the re-appointment of three auditors for FY 2026-27. M/s. Aneja Assurance Pvt. Ltd. (Internal Auditors), M/s. RA & Co. (Cost Auditors), and M/s. R S Sanghai & Associates (Tax Auditors) have all been reappointed for the upcoming financial year. The Cost Auditor appointment is subject to shareholder ratification at the AGM. All three firms are established professional firms with decades of experience in their respective domains — none have any disclosed relationship with company directors.

Likely market impact

This is routine annual compliance and has no material impact on the stock. No auditor changes or concerns were flagged — investors can view this as standard governance housekeeping.